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PDGF Mediates a Neuron–Astrocyte Interaction
in the Developing Retina
Marcus Fruttiger,* Andrew R. Calver,* by cell ablation experiments in transgenic mice. For ex-
ample, if the cells of the eye lens are killed as theyWinfried H. Kru¨ger,† Hardeep S. Mudhar,*
David Michalovich,‡ Nobuyuki Takakura,§ develop (by expressing a toxic gene product under the
control of a lens-specific gene promoter), many otherShin Ichi Nishikawa,§ and William D. Richardson*
*MRC Laboratory for Molecular Cell Biology parts of the eye are secondarily affected and the whole
eye is absent or much reduced in size (Kaur et al., 1989;and Department of Biology
University College London Breitman et al., 1989; Landel et al., 1988). Likewise, ab-
lating the pigmented epithelium has wide-ranging ef-London WC1E 6BT
United Kingdom fects on development of the eye as a whole (Raymond
and Jackson, 1995).†Department of Microbiology
and Program in Neurological Sciences The retina itself is composed of cells with different
developmental origins, whose numbers must presum-University of Connecticut Medical School
Farmington, Connecticut 06030-3205 ably be matched to one another by cell–cell interactions.
Most cells of the neural retina, such as photoreceptors,‡Department of Experimental Pathology
United Medical and Dental Schools neurons, and Mu¨ller glia, are generated by multipotential
neuroepithelial precursors that reside near the outersur-Guy’s Hospital Campus
London SE1 9RT face of the retina (Turner and Cepko, 1987; Wetts and
Fraser, 1988; Holt et al., 1988; Turner et al., 1990). InUnited Kingdom
§Department of Molecular Genetics contrast, retinal astrocytes originate from the optic stalk
and migrate across the inner surface of the retina, start-Faculty of Medicine
Kyoto University ing from the optic nerve head around the day of birth
(Stone and Dreher, 1987; Ling and Stone, 1988; Wata-Shogoin Kawaharacho 53
Sakyo-ku, Kyoto 606-01 nabe and Raff, 1988; Ling et al., 1989). The migrating
astrocytes form a glial network that spreads radially inJapan
close association with the axons of retinal ganglion cells
(RGCs). Patent blood vessels develop in the wake of
the migrating astrocytes (Ling and Stone, 1988; Wata-Summary
nabe and Raff, 1988; Ling et al., 1989), presumably as
a result of interactionsbetween astrocytes and endothe-Astrocytes invade the developing retina from the optic
lial cells (Laterra et al., 1990; for a review, see Chang-nerve head, over the axons of retinal ganglion cells
Ling, 1994). Retinal astrocytes have been shown tomake(RGCs). RGCsexpress theplatelet-derived growth fac-
vascular endothelial cell growth factor (VEGF, alsotor A-chain (PDGF-A) and retinal astrocytes the PDGF
known as vascular permeability factor, VPF) (Alon etalpha-receptor (PDGFRa), suggesting that PDGF me-
al., 1995), which is thought to be crucial for vasculardiates a paracrine interaction between these cells. To
development (Leung et al., 1989; Millauer et al., 1993;test this, we inhibited PDGF signaling in the eye with
Peters et al., 1993; Stone et al., 1995; for a review, seea neutralizing anti-PDGFRa antibody or a soluble ex-
Klagsbrun and Soker, 1993). However, the factors thattracellular fragment of PDGFRa. These treatments in-
control the astrocyte invasion of the retina and develop-hibited development of the astrocyte network. We also
ment of the astrocyte network are unknown.generated transgenic mice that overexpress PDGF-A
We recently found that platelet-derived growth factorin RGCs. This resulted in hyperproliferation of astro-
(PDGF) and its receptors are expressed in the devel-cytes, which in turn induced excessive vasculogen-
oping rodent retina (Mudhar et al., 1993), suggestingesis. Thus, PDGF appears to be a link in the chain of
that PDGF might be important in retinal development.cell–cell interactions responsible for matching num-
PDGF is a covalent dimer of A- and B-chains (AA, BB,bers of neurons, astrocytes, and blood vessels during
or AB) and exerts its biological effects through tworetinal development.
closely related tyrosine kinase receptors (PDGFRa and
PDGFRb) (for review, see Heldin and Westermark, 1989).Introduction
The two receptors have different ligand-binding speci-
ficities; PDGFRa binds all three dimeric isoforms ofDuring development of the vertebrate eye, cells from
PDGF, while PDGFRb binds PDGF-BB and, to a lesserseveraldifferent sourcescome together in a coordinated
extent, PDGF-AB, but not PDGF-AA. Cells in the wallsfashion to form the final structure. The cells of the neural
of blood vessels in the retina (Mudhar et al., 1993) andretina and pigmented epithelium are derived from the
elsewhere in the CNS (Smits et al., 1989; Koyama et al.,neural tube, whereas the eye lens is formed from the
1994b) express PDGFRb or PDGF-B (or both), sug-skin of the embryo as a result of inductive interactions
gesting that PDGF-BB might mediate local interactionsbetween the skin epithelium and the underlying optic
among vascular cells. Furthermore, RGCs expressstalk. Other components of the eye, for example, the
PDGF-A and retinal astrocytes express PDGFRa, lead-ciliary muscles and vascular system, are of mesenchy-
ing us to suggest that PDGF-AA might mediate a short-mal or neural crest origin. For these diverse tissue ele-
ments to assemble correctly requires an intricate net- range paracrine interaction between RGCs and astro-
cytes during development (Mudhar et al., 1993).work of cell–cell communication. This is well illustrated
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To test this idea, we experimentally manipulated proportion of the PDGF-AA and the Ra17 truncated re-
ceptor coprecipitated in this experiment (Figure 1A, lanePDGF-A expression in the developing eye. We inhibited
PDGF activity in vivo using a soluble extracellular frag- 2), demonstrating that the Ra17 polypeptide is capable
of binding to PDGF-AA homodimers in solution, with anment of PDGFRa that can neutralize the activity of all
isoforms of PDGF and also with a neutralizing anti- affinity high enough to withstand the physiological salt
washes performed during the immunoprecipitation pro-PDGFRa monoclonal antibody. In both cases, develop-
ment of the astrocyte network was retarded, strongly tocol.
To assess the ability of the Ra17 truncated receptorsuggesting that PDGF mediates a developmental inter-
action between RGCs and astrocytes. In addition, we to inhibit the mitogenic effect of PDGF, NIH 3T3 cells
were cultured in the presence of PDGF-AA, PDGF-BB,overexpressed PDGF-A in retinal neurons in transgenic
mice. These transgenic animals displayed a striking hy- PDGF-AB, or basic fibroblast growth factor (bFGF) to-
gether with different concentrations of conditioned me-perplasia of retinal astrocytes with their associated
blood vessels, which, in older animals, bore a close dium from COS cells expressing Ra17. DNA synthetic
activity was measured by 3H-thymidine incorporation.resemblance to human proliferative retinopathy. These
results emphasize the obligatory relationships among DNA synthesis induced by all three dimeric isoforms of
PDGF was inhibited, in a dose-dependent manner, byneurons, astrocytes, and vasculature in the retina, and
suggest that PDGF is an important component of the COS cell medium containing Ra17 but not by control
cell medium (Figure 1B). The mitogenic activity of bFGFsignaling network that coordinates growth of these cells
during development. was unaffected by Ra17. These results are consistent
with the known ligand-binding properties of intact
PDGFRa, which can bind and be activated by all three
Results dimeric isoforms of PDGF (Heldin et al., 1988; Gronwald
et al., 1988; Hart et al., 1988). The inhibitory effect of
Sequestering PDGF in the Developing Eye Ra17 on 3H-thymidine incorporation could in turn be
with the Extracellular Domain of PDGFRa overcome by increasing the concentration of PDGF in
Inhibits Formation of the Retinal the medium (data not shown), demonstrating that the
Astrocyte Network PDGF-neutralizing effect of Ra17 is saturable. Under
We wanted to test whether inhibiting PDGF signaling the conditions of our experiments, Ra17-conditioned
can inhibit normal development of the retinal astrocyte medium neutralized between 1 and 3 ng/ml PDGF-AA.
network. We therefore engineered a soluble extracellular A similar truncated PDGFRa was previously shown to
fragment of PDGFRa as a neutralizing agent for all di- inhibit ligand-induced receptor phosphorylation (Yu et
meric isoforms of PDGF (see Experimental Procedures) al., 1994).
and inserted it into a replicating COS cell vector. A Myc COS cells, transfected with pRa17 and injected unilat-
epitope tag, recognized by monoclonal antibody 9E10 erally into the eyes of newborn rats, persisted and con-
(Evan et al., 1985), was inserted in-frame with the trun- tinued to express the Myc-tagged Ra17 truncated re-
cated PDGFRa at its extreme carboxy terminus. The ceptor for several days in vivo (Figures 2B and 2C).
final construct was named pRa17, and the encoded Typically, they formed a compact bolus of cells that
polypeptide Ra17. The construct was electroporated remained attached to the posterior surface of the lens.
into COS cells, which were fixed 72 hr later and labeled The size of the bolus indicated that the COS cells had
with monoclonal antibody 9E10. A proportion of thecells continued to proliferate in the eye following injection.
was labeled, giving intense intracellular labeling of the On postnatal day 5 (P5), injected and contralateral unin-
secretory apparatus (endoplasmic reticulum, Golgi ap- jected eyes were dissected and their retinae processed
paratus, and cytoplasmic vesicles) (Pollock and Rich- for whole-mount histochemistry with a monoclonal anti-
ardson, 1992; see Figure 2A). COS cells transfected with body against glial fibrillary acidic protein (GFAP, a spe-
pRa17 were metabolically labeled with 35S-amino acids cific marker for astrocytes). Eyes that showed signs of
and the cell lysate and supernatant were immunoprecip- having been damaged by the injection procedure (e.g.,
itated with monoclonal antibody 9E10, followed by poly- blood in the vitreous) were rejected, as were eyes that
acrylamide gel electrophoresis and autoradiography. did not appear to have a COS cell tumor and eyes in
The immunoprecipitates from bothcell supernatant (Fig- which the COS cells had invaded the retina (approxi-
ure 1A, lane 1) and cell lysate (data not shown) contained mately half of the injected eyes were analyzed). There
high molecular weight polypeptides that were absent were no significant differences in the radiiof retinae from
from control immunoprecipitations (lane 4). To test the eyes injected with mock-transfected COS cells versus
PDGF-binding ability of the secreted Ra17 polypeptide, uninjected eyes (data not shown), implying that the COS
pRa17 and a similar plasmid encoding the short splice- cells did not inhibit overall growth of the eye. In order
variant of human PDGF-A (Pollock and Richardson, to quantify the effect on astrocyte migration, the retinal
1992) were electroporated separately into cultured COS whole-mounts were divided in six sectors and the dis-
cells, which were subsequently incubated with 35S- tance of the most peripheral astrocyte to the optic nerve
amino acids. The cell culture media were collected and head was measured in each sector. The average of these
coincubated overnight at 48C to allow PDGF-AA to bind six values was taken as a measure of the overall extent of
to the truncated Ra17 receptor. The supernatants were the astrocyte network. For each experimental situation
then immunoprecipitated with an antiserum raised (pRa17-transfected COS cells, mock-transfected COS
cells, contralateral eyes with no COS cell injections), nineagainst pure human PDGF (R and D Systems). A large
PDGF and Retinal Astrocytes
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Figure 1. In Vitro Activity of Ra17 Truncated Receptor
(A) Immunoprecipitation of Ra17 truncated receptor bound to PDGF-AA. COS cells were electroporated with pRa17 or an analogous plasmid
encoding PDGF-A and metabolically labeled with a 35S-methionine/cysteine mixture. Cell culture supernatants were collected and immunopre-
cipitated, either with or without being previously coincubated overnight at 48C with anti–PDGF-AA or 9E10 (anti-c-Myc) antibodies. Precipitates
were run on a polyacrylamide gel and visualized by fluorography. Lane 1: Ra17-conditioned medium (CM) precipitated with anti-c-Myc. Lane
2: Ra17-CM, coincubated with PDGF-A-CM, precipitated with anti-PDGF-AA. Lane 3: Control (mock-transfected)-CM, coincubated with PDGF-
A-CM, precipitated with anti-PDGF-AA. Lane 4: Ra17-CM precipitated with anti-PDGF-AA. Lane M: molecular weight markers. Upper arrow:
position of Ra17 polypeptide. Lower arrow: position of plasmid-encoded PDGF-AA. A proportion of Ra17 and PDGF-AA coprecipitate with
anti-PDGF-AA (lane 2).
(B) Neutralization of PDGF isoforms with Ra17 truncated receptor. Subconfluent cultures of NIH 3T3 cells were growth-arrested by serum
deprivation. Purified growth factors were added to a fixed concentration, sufficient to stimulate half-maximal mitogenic response, together
with different dilutions of conditioned medium from COS cells that had been transfected with plasmid pRa17 (left panel, “Ra17”) or with the
vector backbone alone (right panel, “mock”). After overnight incubation at 378C, 3H-thymidine was added to the cultures for 4 hr before
solubilizing the cells and determining the amount of TCA-precipitable radioactivity by scintillation counting. Assays were performed in triplicate.
The results are expressed as a percentage of the incorporation obtained in response to growth factor alone. Conditioned medium containing
Ra17 truncated receptor was able to neutralize all three dimeric isoforms of PDGF, but not bFGF, in a dose-dependent fashion. For further
details, see Experimental Procedures.
retinae were examined. Careful observation revealed a before birth, prior to the COS cell injections. When the
extent of the astrocyte network in normal newborn ratsslight rotational asymmetry in the normal distribution of
astrocytes in uninjected eyes at P5. In retinae from eyes was subtracted, we found that the distance migrated
by astrocytes during the course of the experiment wasthat had been injected with mock-transfected COS cells,
the GFAP immunoreactivity reflected the normal distri- reduced by 51% 6 18.3% (n 5 9) as a result of exposure
to Ra17.bution of astrocytes (Figure 2D). The radius of the
astrocyte network (estimated as described above) was
only slightly reduced, by 5% 6 3.9% (mean 6 SD, n 5
9), in mock-transfected COS cell–injected eyes when Systemically Delivered Anti-PDGFRa
Immunoglobulin Perturbscompared with contralateral uninjected eyes.
In retinae from eyes that had received COS cells ex- Development of the Retinal
Astrocyte Networkpressing Ra17, development of the astrocyte network
was clearly perturbed (Figure 2E). The effect was not As another means of inhibiting PDGF signaling, we used
a rat monoclonal anti-mouse PDGFRa (antibody APA5)uniform across the retina, being greater in one half of
the retina than the other. In those retinal sectors that that competes with PDGF-AA and PDGF-BB for binding
to PDGFRa on Balb/c-3T3 cells (Takakura et al., 1996)were most affected, the morphology of the network was
altered (compare Figures 2D and 2E), having a less intri- and inhibits PDGF-AA-induced responses in Balb/c-3T3
cells and cultured fetal liver cells (N. T., unpublishedcate branching pattern compared with control retinae.
In addition, the extent of the retinal astrocyte network data). Newborn mice were injected subcutaneously with
50 mg of column-purified APA5 Ig once each day for 3was dramatically reduced in the more affected half of
the retina. To quantify this effect, we compared the radial days, then they were processed for whole-mount immu-
nohistochemistry with anti-GFAP and anti-collagen IV.distances covered by astrocytes in the two most af-
fected sectors of each retina that was exposed to Littermates that had been injected with 50 mg of mono-
clonal rat anti-mouse c-Kit Ig (antibody ACK2) or withpRa17-transfected COS cells with the two shortest dis-
tances measured in each retina that was exposed to vehicle alone served as controls. To test whether the
subcutaneously injected antibodies reached theeye andmock-transfected COS cells; we found a reduction in
the Ra17-treated retinae of 31% 6 9.6% (n 5 9, p < bound to retinal astrocytes, we performed whole-mount
immunohistochemistry with FITC-conjugated goat-anti-0.01 Student’s t-test). However, part of these measured
distances had already been traveled by the astrocytes rat IgG (Figures 3A–3C). In mice injected with APA5, the
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Figure 2. Neutralizing PDGF with an Extra-
cellular Fragment of the PDGFRa Inhibits For-
mation of the Retinal Astrocyte Network dur-
ing Normal Development
(A) Immunofluorescence micrograph of a
COS cell transfected with pRa17 (see Experi-
mental Procedures) and labeled in vitro with
monoclonal 9E10 and fluorescent secondary
antibodies.
(B) Micrograph of a cryosection through an
eye containing an implant of COS cells that
were transfected with pRa17. The cells were
injected at P0 and the eye processed for mi-
crography on P5. The arrow points to the bo-
lus of COS cells adhering to the back of the
lens (L). The dark granules within the COS cell
mass are Ra17-expressing cells visualized by
9E10 immunolabeling followed by an immu-
noperoxidase detection system.
(C) High magnification micrograph of a COS
cell mass like that in (B), labeled with antibody
9E10 followed by fluorescent secondary anti-
bodies. Isolated cells or clusters of cells
within the cell mass label strongly for Ra17
truncated receptor.
(D) and (E) Composite immunofluorescence
micrographs of whole-mount retinae, labeled
with anti-GFAP to visualize the retinal astro-
cyte network.
(D) Part of a normal P5 retina.
(E) Part of a retina from an eye injected at P0
with COS cells expressing Ra17 and pro-
cessed for micrography at P5. The extent of
the astrocyte network is much reduced and
the fine structure of the network is coarser.
Scale bars, 500 mm.
anti-rat IgG-FITC conjugate clearly outlined the astro- IgG immunoreactivity in ACK2-injected mice on an un-
identified subset of retinal cells located near the opticcyte network (Figure 3A), whereas in mice treated with
ACK2 or PBS, no staining above background was ob- nerve head at P5 (data not shown), demonstrating that
ACK2 had reached the retina.served (Figures 3B and 3C). Mice treated with ACK2
showed reduced skin pigmentation as described pre- The retinal astrocyte network (revealed by GFAP im-
munolabeling) in P3 mice injected with APA5 was strik-viously (Nishikawa et al., 1991), indicating that the con-
trol antibody was active. We were able to localize rat ingly perturbed in morphology and reduced in radial
PDGF and Retinal Astrocytes
1121
than normal (Figure 3). As in the Ra17 experiment de-
scribed above, the effect was more pronounced in one
half of the retina than in the other. It is likely that inherent
asymmetrical properties of the developing retina are
the root cause of the uneven effect of systemic APA5
injection (and, by extrapolation, Ra17 treatment too). In
addition to the disturbed morphology of the astrocyte
network found in APA5-injected mice, there was also a
reduction in the extent of astrocyte migration. Combin-
ing data from three independent experiments, the aver-
age radial distance migrated over all six sectors of the
APA5-treated retinae (n 5 13) was reduced by 20% 6
1.2% compared with ACK2-treated retinae (n 5 10).
There is believed to be a close link between the devel-
opment of retinal astrocytes and blood vessels (see be-
low), so we also examined the retinal vasculature in
APA5-injected eyes. There was possibly a small inhibi-
tory effect on the vasculature, but this was much less
pronounced than the effect on astrocytes and we did
not attempt quantitation. Vascular cells do not express
PDGFRa so a direct effect of the antibody on these cells
is not expected.
Transgenic Mice That Overexpress PDGF-A
in Neurons
We generated transgenic mice that express PDGF-A in
subsets of central and peripheral neurons under tran-
scriptional control of the rat neuron-specific enolase
(NSE) gene promoter (Forss-Petter et al., 1990). The
transgene contained a human PDGF-A cDNA engi-
neered to encode the “short” alternative-splice isoform
of PDGF-A with a Myc epitope tag appended to the
carboxy terminus (hPDGF-A; Figure 4A) (Pollock and
Richardson, 1992). The “short” PDGF-A isoform is freely
diffusible in the extracellular fluid, since it lacks the ex-
tracellular matrix-binding motif present at the carboxyFigure 3. Anti-PDGFRa Neutralizing Antibodies Inhibit Normal De-
velopment of the Retinal Astrocyte Network terminus of the “long” PDGF-A isoform (LaRochelle et
(A)–(C) Retinae of mice that were injected subcutaneously in the al., 1991; O¨stman et al., 1991; Khachigian et al., 1992;
neck each day from birth to P3 with rat-anti-mouse PDGFRa Ig (A), Pollock and Richardson, 1992; Raines and Ross, 1992).
rat-anti-mouse c-Kit Ig (B), or vehicle alone (C), then fixed and la- In addition to the NSE-PDGF-A mice, we also gener-
beled with fluorescein-conjugated goat-ant-rat Ig (green). The sec-
ated transgenic mice expressing a closely relatedtions were also labeled with anti-collagen IV and rhodamine-conju-
transgene encoding an endoplasmic reticulum (ER)-gated second antibodies (red). Small sections of the retinae at the
retained form of hPDGF-A (PDGF-AKDEL; Figure 4A).leading edge of the developing vascular net are shown. In each
case, the optic nerve head is outside the field of view to the left. Seven NSE-PDGF-A founders and four NSE-PDGF-AKDEL
The anti-PDGFRa Ig clearly entered the living retina and bound to founders were obtained. Four of the NSE-PDGF-A
the surfaces of astrocyte processes (A). No anti-rat IgG staining can founders (A5-64, -72, -75, -82) and all of the NSE-PDGF-
be detected in mice injected with anti-c-Kit antibody (B) or vehicle AKDEL founders (A10-3, -21, -23, -26) transmitted thealone (C).
transgene to their first offspring and transgenic lines(D) and (E) Mouse retinae injected with anti-c-Kit Ig (D) or anti-
were established. The transgene copy numbers of thePDGFRa Ig (E) as above, fixed and double-labeled for GFAP (green),
lines were all in the range 1–10; the line used for all theand collagen IV (red). Note the reduced and distorted astrocyte
network in anti-PDGFRa-injected mice (E) compared with thenormal experiments described in this paper (A5-75) had about
appearance of the astrocyte network in anti-c-Kit-injected mice (D). five transgene copies per genome. We used a reverse
Scale bar, 200 mm. transcriptase (RT)–PCR approach to examine expres-
sion of transgene-derived hPDGF-A mRNA in the retinae
of each line (e.g., Figure 4B). The PCR primers were
spread when compared with control retinae from ACK2- chosen to amplify PDGF-A transcripts across the Myc
injected mice (Figures 3D and 3E). The ACK2 injections epitope sequences near the 39 end of the transgene.
had no effect on the retinal astrocyte network when Thus, transgene-derived human PDGF-A transcripts
compared with retinae from mice injected with vehicle could be distinguished unambiguously from endoge-
alone. In APA5-injected mice, the astrocytes seemed to nous mouse transcripts by the size of the PCR product
be more fasciculated and possibly reduced in numbers, after Southern blotting and probing with a PDGF-A-spe-
cific oligonucleotide. Reprobing the Southern blot withbecause the astrocyte network had a more open mesh
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Figure 4. Structure and Expression of the
Human PDGF-A Transgene
(A) The transgene consists of human PDGF-A
coding sequences (1.0 kb) with a Myc epitope
tag (44 bp) at its carboxy terminus, under the
control of the rat NSE gene promoter (1.8 kb)
and SV40 polyadenylation site. A second
closely related transgene also had an oligo-
nucleotide encoding an endoplasmic reticu-
lum (ER) retention signal followed by a stop
codon (KDEL.) inserted immediately down-
stream of the Myc tag. See Experimental Pro-
cedures for construction details.
(B) Expression of transgene-derived mRNA
was detected by RT–PCR. Left, diagram
showing the predicted structures of the trans-
genic (hPDGF-A) and endogenous (mPDGF-A)
mRNAs, and the relative positions of oligonu-
cleotide PCR primers (arrows) and hybridiza-
tion probes (P1, P2) used for detection. The
position of exon 6 (69 bp), which encodes an
extracellular matrix binding motif that can be
inserted by alternative splicing, is indicated.
Right, agarose gel electrophoresis of RT–
PCR products generated from line A5-75
transgenic (tg) or wild-type (wt) P3 retinae
and a control reaction (2RT) in which reverse
transcriptase was omitted from thePCR reac-
tion, Southern blotted, and probed with 32P-
labeled probes P1 (detectsall PDGF-A mRNA
species) or P2 (detects only transgene-
derived mRNA). The predicted sizes of the
PCR products are 211 bp (“short” mPDGF-A
mRNA lacking exon 6), 280 bp (“long”
mPDGF-A mRNA including exon 6), or 318
bp (transgenic hPDGF-A mRNA). A series of
control experiments established that our RT–
PCR reaction conditions were such that the
band intensities after blotting were propor-
tional to the amount of mRNA added; band
intensities could therefore be compared on a
semiquantitative basis. Densitometry of gel
lanes indicated that there were about five
times as many transgene-derived PDGF-A
transcripts as endogenous transcripts in the
neural retina of line A5-75, and also that no
“long” form mPDGF-A mRNA can be de-
tected in wild-type or transgenic retinae.
(C) Immunofluorescence localization of transgene-derived hPDGF-A in the retina of a P14 transgenic mouse expressing the ER-retained form
of hPDGF-A (see [A]). Monoclonal 9E10 (anti-c-Myc) was the primary antibody; FITC-conjugated rabbit-anti-mouse IgG was the secondary
antibody. The transgenic retina is on the right, a wild-type littermate on the left. The strongest signal is detected in the cell bodies of retinal
ganglion cells (RGC); a weaker signal is detected in the cell bodies of photoreceptor cells in the outer nuclear layer (ONL, arrowheads), and
in the inner nuclear layer (INL, arrows). The strong signal in the pigment epithelium (PE) is background autofluorescence. Retinal astrocytes
migrate into the retina along the plane of the nerve fibre layer (NFL), which contains the projection axons of RGCs. IPL, inner plexiform layer;
OPL, outer plexiform layer; IS, OS inner and outer segments of the photoreceptor cells. Scale bar, 50 mm.
a specific c-myc oligonucleotide provided further proof We were unable to detect any immunoreactivity over
background in retinae fromany of the NSE-PDGF-A miceof the transgenic derivation of the transcripts (Figure
4B). Three of the four NSE-PDGF-A transgenic mouse using antibody 9E10, which recognizes the Myc epitope
present in the transgene-encoded hPDGF-A. However,lines and two of the four NSE-PDGF-AKDEL lines ex-
pressed transgene-derived mRNA (data not shown). We in both of the NSE-PDGF-AKDEL lines, we could easily
visualize the encoded polypeptide in the cell bodies ofquantified the mRNA expression level in hemizygous
mice of line A5-75 by densitometry of Southern blots in RGCs and, at a lower level, in neurons in the inner and
outer nuclear layers (Figure 4C). The protein was abun-a BioRad Molecular Imager (see Experimental Proce-
dures). At birth, P3, and P14, there were between five dant in all RGCs from before the day of birth (data not
shown) to at least the end of the second postnatal weekand seven times more transgene-derived hPDGF-A tran-
scripts than endogenous transcripts in the neural retinae (Figure 4C) and was still expressed, at a lower level,
in the adult (data not shown). The spatial expressionof these mice. Expression of both transgenic and endo-
geneous PDGF-A declined somewhat in the adult, al- pattern, in particular expression in RGCs, was similar
to that previously described for an NSE-lacZ transgenethough transgenic PDGF-A was still more abundant.
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(Forss-Petter et al., 1990; Seiler and Aramant, 1995) and littermates of one of the lines, called A5-75. At P4, the
homozygous animals displayed a retinal astrocyte phe-an NSE-BCL2 transgene (Martinou et al., 1994), demon-
strating that the activity of the NSE promoter cassette notype that was clearly more severe than that of the
hemizygotes (Figures 5B and 5C). The homozygotesis not markedly affected in cis by flanking chromosomal
sequences at the site of integration. Thus, it seems very (which have a double complement of transgenes and,
presumably, correspondingly higher PDGF-A expres-likely that the expression pattern of the PDGF-AKDEL
transgene is a faithful representation of the expression sion) had a much denser mat of GFAP1 astrocyte pro-
cesses than either the hemizygotes or wild-types (Fig-pattern of the secreted PDGF-A transgene. We con-
clude, therefore, that our NSE-PDGF-A transgenic mice ures 5A–5C). The radial spread of astrocytes from the
optic nerve head was less in the homozygotes than insynthesize the encoded PDGF polypeptide in RGCs and
other retinal neurons but that this does not accumulate the hemizygotes at P4, and less in the hemizygotes than
in wild-type mice (Figures 5A–5C). At P4, for example,to a detectable degree either inside cells or in the extra-
cellular space following secretion. This conclusion is the average radius of the astrocyte net was reduced by
41% 6 10.6% (n 5 10) in heterozygotes and by 59% 6strongly supported by phenotypic analysis of the NSE-
PDGF-A mice (see below). Note that the expression pat- 1.3% (n 5 5) in homozygotes compared with wild type.
Possible reasons for this effect are discussed later.tern of transgene-derived PDGF-A is not dissimilar to
the endogenous pattern of PDGF-A expression (Mudhar However, despite the fact that astrocyte migration was
retarded in A5-75 mice during early postnatal develop-et al., 1993). Both are expressed in the great majority
of RGCs, with no noticeable gradient of expression from ment, the astrocytes did eventually reach all the way to
the periphery of the transgenic retinae.central-to-peripheral at postnatal ages. Endogenous
PDGF-A is also expressed in a subset of amacrine neu-
rons in the inner nuclear layer, whereas transgenic Hypervascularization of the Retina
in NSE-PDGF-A Transgenic MicePDGF-A is expressed in neurons in both the inner and
outer nuclear layers. It is known that astrocytes influence retinal vasculogen-
esis during normal development (see Discussion), so weThe RT–PCR assay was also able to distinguish
between endogenous mouse mRNAs that encoded predicted that the increased number of astrocytes in
NSE-PDGF-A transgenic retinae might in turn inducethe “short” and “long” alternative splice isoforms of
PDGF-A. Only the “short” isoform was detected in wild- overproduction of blood vessels. We used antibodies
against GFAP and collagen IV to specifically labeltype or transgenic mice, demonstrating that only this
isoform is normally produced in the P3 mouse retina. astrocytes and blood vessels (Herken et al., 1990; Con-
nolly, 1991), respectively. We compared thegliovascular
nets in retinae of P4 wild-type, hemizygous, and homo-
Hyperplasia of the Retinal Astrocyte Network zygous transgenic (A5-75) animals (Figures 5D–5F).
in NSE-PDGF-A Mice There was a striking correspondence between the
During normal development, retinal astrocytes migrate astrocyte and vascular nets in all three genotypes; not
radially across the inner surface (i.e., the nerve fiber only was there transgene dose-dependent overproduc-
layer) of the retina from the optic nerve head, starting tion of blood vessels in the transgenic retinae, but the
around the day of birth and reaching the periphery of distribution of vessels closely matched the distribution
the retina around postnatal day 5 (P5) in the rat and the of astrocyte processes; that is, the vessels did not
mouse (Watanabe and Raff, 1988; Mudhar et al., 1993; spread further than the astrocytes. The correspondence
M. F., unpublished data). Since retinal astrocytes ex- between astrocytes and blood vessels is particularly
press PDGFRa (Mudhar et al., 1993), which can be acti- obvious in Figures 5C and 5F, which depict the same
vated by all three dimeric isoforms of PDGF (AA, AB, homozygous retina labeled with both antibodies. Thus,
BB), we expected that development of retinal astrocytes not only is there a higherdensity of vessels in retinae that
might be perturbed in the NSE-PDGF-A mice. Immuno- contain more astrocytes, but the distribution of vessels
histochemistry with antibodies against GFAP revealed seems to be restricted by the extent of the astrocyte
that all three transgenic lines that expressed transgene- network. This emphasizes the interdependence of
derived mRNA displayed hyperplasia of the retinal astrocytes and blood vessels during both normal and
astrocyte network (Figure 5). The fourth NSE-PDGF-A abnormal retinal development.
line (A5-72) that did not express the transgene had no During early postnataldevelopment, the NSE-PDGF-A
phenotype (data not shown), demonstrating a correla- retinae displayed retinal hemorrhage, especially in ho-
tion between transgene expression (at the mRNA level) mozygous animals (data not shown). This might be a
and phenotype. It is noteworthy that neither of the two result of overproduction of vascular endothelial cell
NSE-PDGF-AKDEL transgenic lines had any retinal pheno- growth factor/vascular permeability factor (VEGF/VPF)
type, despite the fact that the ER-retained PDGF-A ac- by the excess astrocytes in these retinae. Retinal
cumulated to a high level in RGCs of these mice (Figure astrocytes have been shown to express VEGF/VPF in an
4C). This provides strong genetic evidence that the phe- oxygen-dependent manner during normal development
notype of the NSE-PDGF-A mice depends on the ability (Shweiki et al., 1992; Stone et al., 1995).
of the transgene-derived PDGF protein to be secreted
from the cells that synthesize it. Retinal Astrocytes in NSE-PDGF-A Mice Are More
We investigated the transgene dose dependence of Numerous and Proliferate More than Normal
the retinal astrocyte phenotype of NSE-PDGF-A mice To confirm that the abnormal appearance of the astro-
cyte net in NSE-PDGF-A mice was due to increasedby comparing hemizygous and homozygous transgenic
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Figure 5. Hyperplasia, but Decreased Migra-
tion, of Retinal Astrocytes and Blood Vessels
in NSE-PDGF-A Transgenic Mice
Retinal astrocytes (A–C) and inner vascula-
ture (D–F) in P4 wild-type (A and D), hemizy-
gous transgenic (B and E), and homozygous
transgenic (C and F) littermates were visual-
ized by anti-GFAP labeling (A–C) and anti-
collagen IV labeling (D–F) of retinal whole-
mounts. Only part of each preparation is
shown, including the optic nerve head (bot-
tom) and one lobe of the whole-mount. With
increasing hPDGF-A transgene dose, the
astrocyte network becomes more dense, and
advances less far from the optic nerve head.
The vasculature in the wild-type retina (D)
forms an even network that does not yet ex-
tend all the way to the retinal periphery, even
though astrocytes have already reached the
periphery (compare with [A]). In the hemizy-
gous transgenic animal (E), the retinal vessels
form a denser network; there appear to be
more and thicker vessels compared with
wild-type. Note that the transgenic vascular
net extends approximately to the leading
edge of the astrocyte net, but does not over-
take it (compare with [B]). In the homozygous
transgenic retina (F), the vasculature forms
a dense mat and extends a relatively short
distance from the optic nerve head, closely
corresponding to the distribution of astro-
cytes (compare with [C], which shows the
same retina double-labeled for GFAP). Thus,
the distribution of blood vessels in the
transgenic retinae appears to be determined
by the distribution of astrocytes. In (F), note
vessels growing away from the retina into the
vitreous (arrows). Scale bar, 200 mm.
numbers of astrocytes rather than, for example, more astrocytes in the transgenic retinae. For example, it is
possible that increased survival of astrocytes also con-extensive GFAP1 processes on the same number of
cells, we enzymatically dissociated individual retinae tributes to the phenotype.
from P3 and P6 wild-type and transgenic (A5-75) retinae
and labeled them in suspension with anti-GFAP antibod- Adult NSE-PDGF-A Mice Display a Phenotype
Resembling Human Proliferative Retinopathyies followed by FITC-conjugated second antibodies. The
cells were also incubated with propidium iodide (PI) to In normal adult retinae, astrocytes are only found on the
inner surface and never deep within the retina (Figurelabel nuclear DNA and analyzed in a fluorescence-acti-
vated cellscanner (FACS). Representative primary FACS 7A). In adult transgenics, the astrocytes formed an ab-
normally tight mesh on the inner surface of the retinadata for one wild-type and one hemizygous transgenic
mouse are shown in Figures 6A and 6B, and combined (data not shown) and, in addition, penetrated into the
neural retina to form abnormal extensions of the netdata from several animals are plotted in Figures 6D and
6E (details in the figure legend). A control in which the throughout the retina and even as deep as the retinal
pigmented epithelium (Figure 7B).primary antibody (anti-GFAP) was omitted is shown in
Figure 6C. Cells with GFAP labeling greater than back- In adult wild-type mice, blood vessels are limited to
well defined planes at the inner surface of the retina andground (boxed regions in the FACS plots of Figures
6A–6C) were counted as a proportion of the total retinal in the plexiform layers (arrows in Figure 7C), where they
border the inner nuclear layer (Engerman and Meyer,cell population. There were more than twice the normal
number of GFAP1 astrocytes in the transgenic retinae 1965; Connolly, 1991). The outer vascular network devel-
ops during the second postnatal week by budding fromat P3, and about four times the normal number at P6
(Figure 6D). In the transgenic retinae, there was also a the inner vasculature, and is independent of astrocytes
(Engerman and Meyer, 1965; Stone et al., 1995). In adulthigher proportion of astrocytes in the S, G2, and M
phases of the cell cycle (15.6% 6 2.4% compared with hemizygous transgenics, blood vessels penetrated into
all layers of the retina right out to the photoreceptor10.4% 6 1.0% inwild type, means 6 SDs). This suggests
that proliferation of astrocytes is enhanced in the layer (arrows in Figure 7D). Confocal microscopy re-
vealed that they were colocalized with GFAP1 glial cells,transgenic retinae. We cannot yetsay whether this effect
accounts completely for the increased number of most likely astrocytes (data not shown). The lamellar
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suggests that PDGF-A might mediate a short-range par-
acrine interaction between these two cell types during
normal development (Mudhar et al., 1993). The experi-
ments reported here were designed to test whether such
an interaction does occur and, if so, what the nature of
the interaction might be. We attempted to inhibit PDGF
signaling through PDGFRa on astrocytes, both with a
blocking anti-PDGFRa antibody and also with a soluble
extracellular fragment of PDGFRa. Both treatments re-
sulted in significant but incomplete inhibition of astro-
cyte migration and a reduced branching pattern of the
astrocyte network. Because we cannot tell to what ex-
tent PDGF signaling was inhibited in our experiments,
we cannot deduce whether PDGF is wholly or only partly
responsible for astrocyte proliferation/migration during
development. It is possible that development of the
astrocyte network depends solely on PDGF and that our
inhibitory regimes were inadequate to reveal this. It is
perhaps more likely that PDGF normally acts in concert
with other factors whose individual contributions to
astrocyte development are relatively small but whose
combined effects are cumulative. If so, eliminating any
one of them would not necessarily have a catastrophic
effect.
To gain further information about the activity of
PDGF-A in the retina, we generated transgenic mice that
express PDGF-A under control of the NSE promoter.
Although we were unable to visualize the transgene-
derived secreted PDGF-A directly in situ, we showed,
in two independent lines of transgenic mice, that an ER-
retained form of PDGF-A under NSE control is expressed
Figure 6. FACS Analysis of Astrocytes in Retinae of Wild-Type and strongly in RGCs and less strongly in other retinal neu-
Transgenic Littermates rons. This is in accord with experience of other NSE-
(A–C) Primary data for dissociated P3 retinal cells sorted by anti- driven transgenes (Forss-Petter et al., 1990; Seiler and
GFAP fluorescence intensity (ordinate) and propidium iodide (PI) Aramant, 1995; Martinou et al., 1994), demonstrating
fluorescence intensity (abscissa).
that the activity of the NSE promoter cassette in the(A)–(C) Wild-type (A) and hemizygous transgenic (B and C) retinal
retina is robust, reproducible, and refractory to cis-act-cells. The anti-GFAP antibody was omitted in (C).
ing effects of the transgene or neighboring chromo-(D) Cells falling within the gate represented by the rectangular boxes
in (A)–(C) (i.e., GFAP1 astrocytes) were plotted as a proportion of somal sequences. The ER-retained PDGF-A transgene
the total number of retinal cells (mean and SDs of twelve wild-type did not elicit any retinal phenotype, unlike the secreted
and five transgenic animals from two P3 litters, twelve wild-type PDGF-A transgene, providing strong genetic evidence
and three transgenic animals from two P6 litters). Since the total
that the phenotype of our NSE-PDGF-A mice resultsnumber of retinal cells did not change significantly in the transgenic
from synthesis and secretion of the encoded PDGF-Aanimals (data not shown), there are approximately twice as many
polypeptide. Therefore, our transgenic mice demon-astrocytes as normal in the P3 transgenic retinae, and four times
as many in the P6 transgenic retinae. strate that increasing the supply of PDGF-A, most likely
(E) Numbers of GFAP1 astrocytes in the S/G2 and M phases of the from RGCs (which also express endogenous PDGF-A),
cell cycle (PI fluorescence greater than 240 arbitrary units in [A]–[C]) dramatically enhances accumulation of neighboring reti-
were plotted as a proportion of the total number of astrocytes in nal astrocytes and their associated blood vessels. FACS
each retina (means and SDs of six wild-type and three transgenic
analysis showed that the proportion of astrocytes con-animals from one P3 litter). A greater proportion of astrocytes in
taining more than a diploid complement of DNA is alsothe transgenic retinae is in S/G21M compared with their wild-type
increased. One possible interpretation of this observa-littermates.
tion is that the time the cells spend in G1 is reduced in
proportion to the time spent in S/G2 and M, that is, the
cell cycle is accelerated. Alternatively, the proportion ofstructure of the retina was disrupted in places, presum-
astrocytes that is actively engaged in thecell cycle mightably a physical effect of the invading vasculature (large
be increased in the transgenic mice. At present, wearrow, Figure 7D).
cannot distinguish between these possibilities. Never-
theless, we can conclude from the present data that
Discussion PDGF-A overproduction in the transgenic mice has a
positive effect on retinal astrocyte proliferation. It is pos-
The fact that PDGF-A and PDGFRa are expressed in sible that there is also an effect on astrocyte survival.
The fact that increased levels of PDGF-A stimulatethe rodent retina by RGCs and astrocytes, respectively,
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Figure 7. Retinae of Adult NSE-PDGF-A
Transgenic Mice Have Similarities to Human
Proliferative Retinopathies
Sections through adult wild-type (A and C)
and hemizygous transgenic (B and D) retinae
were immunolabeled with anti-GFAP to re-
veal the distribution of astrocytes (A and B)
or stained with methylene blue and photo-
graphed in bright-field to show retinal mor-
phology (C and D). Whereas astrocytes in the
wild-type retina (A) are restricted to the inner
surface (nerve fiber layer), astrocytes are dis-
tributed through all retinal layers right out to
the pigment epithelium in the transgenic ret-
ina (B). This aberrant distribution of astro-
cytes is reflected by the vasculature in the
transgenics. Whereas blood vessels in the
wild-type retina are restricted to the nerve
fiber layer and to the inner and outer faces
of the inner nuclear layer (small arrows in [C]),
they are more abundant and are distributed
throughout the depth of the transgenic retina
(small arrows in [D]). Presumably because of
this vascular invasion of the retina, the normal
lamellar organization of the retina is disrupted
in places (e.g., large arrow in [D]). Scale bars,
50 mm.
astrocyte proliferation demonstrates that neither PDGF-A abolished at higher concentrations (12 ng/ml), whereas
the proliferative response to PDGF-AA is monophasicnor any other mitogenic factor is available in the normal
developing mouse retina at a concentration that is satu- and reaches a plateau at comparatively high concentra-
tions (25 ng/ml) (Abedi et al., 1995). PDGF-AA has alsorating for astrocyte proliferation. It follows that the num-
ber of astrocytes that develop in the retina could poten- been reported to antagonize PDGF-BB-stimulated cell
migration (Siegbahn et al., 1990; Koyama et al., 1992).tially be determined by the rate of supply of PDGF-A,
which in turn depends on the number of RGCs. It is It seems likely that the signal transduction pathways
that stimulate cell proliferation and migration interactknown that the final number of RGCs, in common with
many other neuronal populations, depends on survival but, in general, the relationship between proliferation
and migration is poorly understood. An alternative ex-signals from their target cells. It is also strongly sus-
pected that the number of vascular cells that develop planation for the altered distribution of astrocytes in the
transgenic retinae might be that this reflects an alteredin the retina depends on astrocytes (see below), and
the data presented here support this idea. Therefore, expression pattern of PDGF-A. We think that this is less
likely, because the postnatal expression pattern of ourthere appears to be a hierarchy of sequential cell–cell
interactions among vascular cells, astrocytes, RGCs and ER-retained form of PDGF-A and other NSE-driven
transgenes (Forss-Petter et al., 1990; Martinou et al.,their target cells, the purpose of which is to ensure
that each cell population develops in proportion to the 1994; Seiler and Aramant, 1995) is rather similar to the
expression pattern of endogeneous PDGF-A (Mudharothers. We suggest that PDGF-AA is an important link
in this chain of number-matching interactions, acting et al., 1993). Both transgene-derived and endogenous
PDGF-A are expressed in the great majority of RGCs allas an RGC-derived mitogen for astrocytes and thereby
controlling the proportion of astrocytes to RGCs. the way from optic nerve head to the retinal periphery,
and in other retinal neurons in the inner and outer nuclearAn unexpected finding was that, despite the consider-
able increase in astrocyte numbers in the transgenics, layers.
A striking aspect of the transgenic phenotype was themigration away from the optic nerve head was retarded.
Superficially, it might appear that stimulating and inhib- closecorrespondence between thedistribution patterns
of retinal astrocytes and blood vessels. In wild-typeiting PDGF signaling have similar effects on the astro-
cyte network but this is not so; inhibiting PDGF signaling mice, the astrocytes migrate from the optic nerve head
slightly ahead of the developing vascular network. Inwith the Ra17 truncated receptor or APA5 anti-PDGFRa
Ig resulted in a less extensive and more sparse astrocyte transgenic retinae, where astrocyte migration was re-
tarded, the leading edge of the blood vessels caughtnetwork, whereas increasing PDGF supply in the trans-
genics resulted in a less extensive but much denser up with but did not overtake the astrocyte front. This
was true even in homozygous transgenic retinae, wherenetwork. PDGF-AA has been reported toeither stimulate
or inhibit cell migration, depending on its concentration astrocyte migration was severely inhibited. This is con-
sistent with the view that physical proximity of astro-and the cell type under investigation (Ferns et al., 1990;
Siegbahn et al., 1990; Uren et al., 1994; Koyama et al., cytes is required for retinal vasculogenesis. Retinal
astrocytes express PDGFRa and probably respond di-1994a; Iguchi et al., 1995). For example, migration of
Swiss 3T3 fibroblasts in vitro is maximal at relatively rectly to the transgene-encoded hPDGF-A. However,
vascular cells express PDGFRb (Mudhar et al., 1993)low PDGF-AA concentrations (3 ng/ml) and completely
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and would not beexpected to respond directly to PDGF- 1991). Therefore, our transgenic mice might model a
naturally occurring human disease state and couldAA (Heldin et al., 1988; Coats et al., 1994). In keeping
with this expectation, neither pericytes nor endothelial prove useful for testing potential treatments for some
aspects of the proliferative retinopathies.cells respond to PDGF-AA in vitro (D’Amore and Smith,
1993). Therefore, vascular cells in the transgenic retinae
are probably stimulated by secondary signals from the Experimental Procedures
PDGF-AA-responsive astrocytes. A strong candidate for
Construction of pRa17 Plasmid Expression Vectoran astrocyte-derived vasculogenic factor is VEGF/VPF
A full-length cDNA encoding rat PDGFRa (Lee et al., 1990) was(Barinaga, 1995). This factor is synthesized by retinal
obtained from R. Reed (John Hopkins, Baltimore). A 1.7 kb fragmentastrocytes in vivo (Stone et al., 1995), and is regulated
of this cDNA was obtained following digestion with EcoRI and NotI,
by oxygen tension both in vivo and in vitro. Thus, experi- and inserted into a COS cell expression vector based on pHYK
mentally induced hypoxia results in up-regulation of (Pollock and Richardson, 1992), which contains the adenovirus ma-
jor late promoter, polyadenylation site from the herpesvirus type-1VEGF mRNA and stimulates vasculogenesis (Shweiki et
thymidine kinase gene, and simian virus 40 origin of replication. Thisal., 1992; Alon et al., 1995; Pierce et al., 1995; Stavri et
vector can replicate autonomously in COS cells under the influenceal., 1995; Stone et al., 1995), whereas hyperoxia has the
of the endogenous SV40 large-T antigen. The PDGFRa insert in-reverse effect (Alon et al., 1995). We did not investigate cludes a small amount of 59 noncoding sequence, followed by the
VEGF expression in our transgenic mice, but the fact initiation codon and coding sequence up to, but not including, the
that the overextended retinal vasculature was leaky and transmembrane domain. The mode of construction also placed a
c-Myc epitope tag in-frame at the extreme carboxy terminus ofreleased blood into the retina is consistent with the
the encoded receptor fragment, so that it could be recognized byknown activities of VEGF/VPF (Connolly, 1991).
monoclonal antibody 9E10 (Evan et al., 1985). The final constructIn adult NSE-PDGF-A transgenic retinae, astrocytes
was named pRa17, and the encoded polypeptide Ra17.were distributed throughout the depth of the retina, in-
cluding the inner and outer plexiform layers and as far
Electroporation of COS Cells
out as the retinal pigment epithelium. This is in striking DNA-encoding truncated rat PDGFRa (Ra17) or a similar plasmid
contrast to wild-type retinae, in which astrocytes are encoding the short splice-variant of human PDGF-A (Pollock and
found only at the inner retinal surface (Stone et al., 1995). Richardson, 1992) was introduced into cultured COS cells by elec-
troporation. The cells were grown to about 70% confluence in Dul-It seems likely that this is a consequence of overexpres-
becco’s modified Eagle’s medium (DMEM) containing 10% fetal calfsion of the NSE-PDGF-A transgene in neurons of the
serum (FCS), trypsinized, and washed twice in HBS (20 mM Hepesinner and outer nuclear layers (Forss-Petter et al., 1990;
[pH 7.05], 137 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4, 6 mMFigure 4C), although it is unclear how the effect is elic-
D-glucose), and resuspended in HBS at a concentration of 8 3 106
ited. For example, PDGF-A overexpression might trigger cells/ml. We mixed 2 3 106 cells with 15 mg of DNA and electropor-
abnormal outward migration of astrocytes into the ret- ated with a Biorad apparatus at 320 V and 125 mF, giving a time
constant of 4.9 ms. After electroporation, the cells were grown inina, or it might allow inappropriate survival of astrocytes
DMEM containing 10% FCS for 48 hr on plastic tissue culture dishesthat might normally migrate outward but that usually
prior to intravitreal injection (see below) or on glass coverslips fordie for lack of survival signals. It is likely that these
immunocytochemistry with anti-c-Myc monoclonal antibody 9E10.
inappropriately located astrocytes are responsible for
inducing the excessive and misplaced vascularization
Metabolic Radiolabeling of COS Cells
that is observed throughout the depth of the adult About 5 3 105 electroporated COS cells were plated into 25 cm2
transgenic retina. tissue culture dishes and grown for 48 hr before washing once with
Inappropriate vascularization of the retina is the hall- phosphate-buffered saline (PBS). The culture medium was replaced
with cysteine- and methionine-free DMEM containing 10% dialysedmark of proliferative retinal diseases, such as prolifera-
fetal calf serum (FCS) and 60 mCi/ml 35S-cysteine/methionine mix-tive diabetic retinopathy (PDR) or age-related macular
ture (Translabel, Amersham). After 16 hr incubation, the cell superna-degeneration; in each of these human disorders, inap-
tant was centrifuged at 25,000 3 g for 20 min and stored at 48C
propriate neovascularization of the retina can lead to before use.
blindness (D’Amore, 1994; Barinaga, 1995). VEGF is now
thought to play a key role in ischemia-associated reti- Immunoprecipitation and Gel Electrophoresis
nopathies such as PDR and retinopathy of prematurity 35S-labeled supernatants from COS cells expressing truncated rat
(Aiello et al., 1994; D’Amore, 1994; Alon et al., 1995; PDGFRa, or human PDGF-A, were preincubated with 1023 volume
of normal mouse serum for 1 hr at 48C, then with protein A-Sepha-Barinaga, 1995; Pe’er et al., 1995). Retinal astrocytes
rose for 1 hr, followed by centrifugation at 15,000 3 g for 10 min.are known to produce VEGF (see above) and are thought
The Ra17 supernatant was then incubated with an equal volume ofto participate in the pathogenesis of human retinopa-
either DMEM or PDGF-A supernatant for 16 hr at 48C. The superna-
thies (Jerdan et al., 1986; Sramek et al., 1989; Ohira and tants were immunoprecipitated with either mouse monoclonal anti-
de Juan, 1990; Hosada et al., 1993; Alon et al., 1995). body 9E10 or rabbit antiserum raised against PDGF from human
Thus, factors that influence astrocytes (such as PDGF- platelets (R and D Systems, Minneapolis). After precipitation of im-
mune complexes with protein A-Sepharose, they were electropho-AA) might be expected to deregulate VEGF production,
resed on a 10% nonreducing polyacrylamide gel containing SDSresulting in neovascularization. PDGF and PDGF recep-
and visualized by fluorography (Bonner and Laskey, 1974).tors have previously been implicated in the pathogene-
sis of human proliferative retinopathies (Robbins et al.,
3H-Thymidine Incorporation Assays1994). Human serum levels of PDGF (50–70 ng/ml) are
Approximately 2 3 104 NIH 3T3 cells were plated in each well of a
high enough that, following intraocular hemorrhage, the 24-well tissue culture plate and cultured overnight in DMEM con-
retina might be exposed to concentrations of PDGF that taining 10% FCS. After two washes with DMEM, the cells were
would be sufficient to reinitiate astrocyte proliferation growth-arrested by incubation in DMEM containing 0.25% FCS for
30 hr. DMEM-containing recombinant PDGF homodimers or bFGFand subsequent neovascularization (Uchihori and Puro,
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(all human sequence, from Peprotech, New York), or PDGF-AB puri- PDGFRa in vitro (Takakura et al., 1996). Hybridoma culture-superna-
tants were precipitated with saturated amonium sulfate at 50% (v/v)fied by metal ion chromatography from human platelets (Ham-
macher et al., 1988; a generous gift from Carl-Henrik Heldin), with concentration. The precipitate was further purified by anion-
exchange chromatography (Clezardin et al., 1985). A monoclonalor without medium conditioned by COS cells expressing Ra17, was
added to the cells, which were cultured for a further 16 hr at 378C rat antibody (IgG 2a) against mouse c-Kit (clone ACK2; Nishikawa
et al., 1991) was used as a negative control for the effects of APA5.before the addition of 1–3 mCi of 3H-thymidine. The concentrations
of growth factors used were sufficient to exert a half-maximal effect Fluorescein isothiocyanate (FITC)-conjugated anti-mouse antibod-
ies, FITC-conjugated anti-rat antibodies, FITC-conjugated anti-rab-on 3H-thymidine incorporation in the absence of any conditioned
medium: 2 ng/ml for PDGF-AA and PDGF-AB, and 0.5 ng/ml for bit antibodies, and tetramethyl rhodamine isothiocyanate (TRITC)-
conjugated anti-rabbit antibodies (Sigma Immuno Chemicals) werePDGF-BB and bFGF. After 4 hr incubation in the presence of
3H-thymidine, the medium was removed and the cells lysed and used as secondary antibodies.
washed in situ three times with ice-cold 5% (w/v) trichloracetic
acid (TCA). The precipitates remaining attached to the plastic were Production of Transgenic Mice
solubilized in 0.5 M NaOH, 1% (w/v) sodium dodecyl sulfate (SDS). Mice that overexpress PDGF-A in neurons under control of the NSE
The incorporated radioactivity was estimated by scintillation count- gene promoter were generated at the UMDS Transgenic Unit, The
ing in Aquasol (Dupont). Rayne Institute, St. Thomas’s Hospital, London SEI 7EH. The trans-
gene consisted of a partial human PDGF-A cDNA (Betsholtz et al.,
1986) engineered to encode the “short” alternative splice PDGF-AIntravitreal Injection of COS Cells
isoform (Tong et al., 1987; Bonthron et al., 1988; Rorsman et al.,For injection into the eyes of newborn rats, COS cells were cultured
1988) with a Myc epitope tag (Evan et al., 1985) at its carboxyfor 48 hr after electroporation, trypsinized and washed, and resus-
terminus, fused to the rat NSE promoter (Forss-Petter et al., 1990)pended in HEPES MEM at a concentration of z2 3 106 cells/ml. In
and the SV40 early polyadenylation site (Figure 4A). In brief, the SacIIparallel, COS cells on coverslips from the same electroporation
site upstream of the initiation codon in plasmid “PDGF-AS1TAG”experiment were subjected to immunofluorescence microscopy
(Pollock and Richardson, 1992) was converted to a HindIII site by T4with antibody 9E10 to monitor expression levels. COS cells were
bacteriophage DNA polymerase treatment and addition of a HindIIInot used for intravitreal injection unless the proportion expressing
linker, then a HindIII–EcoRI fragment containing the complete hu-Ra17 was greater than 15%. Approximately 103 cells (0.5 ml) were
man PDGF-A coding sequence with Myc tag attached and part ofinjected into the posterior chamber of one eye of newborn rat pups.
the PDGF-A mRNA 39 untranslated region was excised and used toThe neonates were anesthetized with Metofane (C-Vet Ltd., Bury St.
replace the lacZ fusion gene in plasmid “NSElacZ” (Forss-Petter etEdmunds), and the eyelids eased apart using a pair of microscissors
al., 1990), leaving the SV40 poly(A)-addition site intact. This placedunder a dissecting microscope. Using a Hamilton syringe with a 34
human PDGF-A under the control of 1.8 kb of rat NSE promotergauge needle, the cells were injected over a period of 2 min. After
sequences and the SV40 early poladenylation site. The entire NSE-completion of the injection, the needle was left in position for 30 s
PDGF-SV40 cassette was purified as a linear EcoRI fragment forto reduce reflux of the injected cells. Control injections of mock-
injection into mouse oocytes (C57Bl/6 3 CBA f1 hybrids).electroporated COS cells, or the vehicle alone, were always con-
ducted on rats from the same litter.
Identification and Genotyping of Transgenic Animals
Tail clippings were digested overnight at 558C in a buffer containing
Histology and Immunocytochemistry 50 mM Tris (pH 8), 10 mM EDTA, 100 mM sodium chloride, 1%
For whole-mount preparations, eyes were removed and given a brief (w/v) SDS, and 50 mg/ml proteinase K (Sigma). Following RNase A
fixation in 4% (w/v) paraformaldehyde in phosphate-buffered saline treatment (100 mg/ml, 1 hr at 378C), ammonium acetate was added
(PBS). The retinae were subsequently dissected and fixed in ice- to a final concentration of 2 M, chilled on ice, and centrifuged to
cold methanol. After incubating in PBS containing 50% fetal calf precipitate proteins. DNA in the supernatant was precipitated with
serum (FCS) and 1% (w/v) Triton X-100 for 30 min at room tempera- 0.6 vol of cold isopropanol and washed with 70% ethanol. The DNA
ture, the retinae were incubated overnight at room temperature in pellet was dissolved in water overnight at 48C. Yields were estimated
primary antibody, washed for 1 hr in PBS, incubated for 3 hr at room from absorbance at 260 nm, and DNA aliquots (10 mg) were digested
temperature in fluorescent secondary antibody, washed for 1 hr, with restriction enzymes and subjected to Southern blot analysis.
and mounted in Citifluor anti-fade reagent (City University, London). The blots were hybridized with a PDGF-A chain cDNA probe radiola-
All antibodies were diluted in PBS containing 10% FCS. For cryosec- beled by random priming (Feinberg and Vogelstein, 1984).
tions, eyes were removed and fixed in 4% (w/v) paraformaldehyde
in PBS for 1 hr and cryoprotected in 30% (w/v) solution of sucrose RT–PCR
in PBS. Retinae were dissected in PBS, embedded in OCT (Raymond Retinae were dissected from wild-type and transgenic littermates
A. Lamp, London), and frozen in isopentane cooled by liquid nitro- and homogenized in guanidinium isothiocyanate, and total cellular
gen. Cryosections (12 mm nominal thickness) were prepared and RNA was prepared as described previously (Chomczynski and Sac-
stained as previously described (Mudhar et al., 1993). For semithin chi, 1987). This was treated with 400 units/ml RNase-free DNase 1
sections, deeply anaesthetized animals were perfused with cacodyl- (Pharmacia) for 15 min at 378C, then phenol/chloroform-extracted
ate buffer (0.1 M [pH 7.4]) containing 4% (w/v) paraformaldehyde and precipitated with ethanol. Total RNA (2 mg) was reverse-tran-
and 2% (w/v) glutaraldehyde. Retinae were dissected, fixed in caco- scribed into cDNA using the Superscript preamplification system
dylate buffer containing 2% (w/v) OsO4, dehydrated in ethanol, and (Gibco-BRL). PDGF-A sequences were then specifically amplified
embedded in TAAB resin (TAAB Laboratories Equipment Ltd., En- by PCR (25 cycles of the following): 948C, 30 s; 558C, 2 min; 728C,
gland). Semithin sections (1 mm nominal thickness) were stained 2 min; concluding with 728C, 10 min). The PCR primers were as
with methylene blue, 0.2% (w/v) in water. follows: 59-GTCCAGGTGAGGTTAGAGGA-39 (upstream) and 59-TCA
CGGAGGAGAACAAAGAC-39 (downstream). These hybridized to
both endogenous (mouse) and transgenic (human) PDGF-A se-Antibodies
For whole-mount preparations, a mouse monoclonal antibody quences without mismatch. RNA titration experiments showed
that the RT–PCR reaction was semiquantitative under these condi-raised against pig glial fibrillary acidic protein (GFAP) (Sigma Im-
muno Chemicals) and a polyclonal rabbit antibody raised against tions (i.e., operating in the linear range). The PCR products were
separated on a 2% (w/v) agarose gel, which was Southern blottedmurine collagen IV (Biogenesis, England) were used as primary anti-
bodies. A polyclonal rabbit anti-GFAP antibody (Pruss, 1979) was onto nylon membrane (Zetaprobe, BioRad) and probed with 32P-
labeled (using polynucleotide kinase) oligonucleotide probesused in flow cytometry. The latter anti-GFAP antibody and mono-
clonal antibody 9E10 (Evan et al., 1985) were used for immunohisto- against either PDGF-A or the Myc epitope tag (see Figure 4). The
oligonucleotide probe against PDGF-A was an equimolar mixturechemistry on cryosections. The monoclonal antibody (IgG 2a)
against PDGFRa (clone APA5) was raised against recombinant of two 39-mers, 59-AAGCACCATACATAGTATGTTCAGGAATGTCA
CACGCCA-39 (mouse) and 59-AAGCACCGTACATAGTAGGTTCAGGmouse PDGFRa in rat and competes with PDGF for binding to
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AATGTAACACGCCA-39 (human). The probe for Myc sequences was Breitman, M.L., Bryce, D.M., Giddens, E., Clapoff, S., Goring, D.,
Tsui, L.-C., Klintworth, G.K., and Bernstein, A. (1989). Analysis ofa 44-mer oligonucleotide, 59-CCTGAGCAAAAGCTCATTTCTGAAG
AGGACTTGCTCGAGTA GCC-39. The blots were exposed and lens fate and eye morphogenesis in transgenic mice ablated for
cells of the lens lineage. Development 106, 457–463.scanned using a BioRad GS-250 Molecular Imager with a BI screen
to quantitate band intensities. Chang-Ling, T. (1994). Glial, neuronal and vascular interactions in
the mammalian retina. Prog. Retinal Res. 13, 357–389.
Flow Cytometry Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA
Retinae were dissected and collected in Mg21/Ca21-free Earl’s basal isolation by acid guanidinium thiocyanate-phenol-chloroform ex-
salt solution (EBSS; Gibco) and incubated for 1 hr at 378C in 0.125% traction. Anal. Biochem. 162, 156–159.
(w/v) trypsin (Sigma) in EBSS followed by 30 min at 378C in 0.125%
Clezardin, P., McGregor, J.L., Manach, M., Boukerche, H., and De-(w/v) type I collagenase (Sigma) in DMEM. Cells were mechanically
chavanne, M. (1985). One-step procedure for the rapid isolation ofdissociated by trituration through a yellow Eppendorf tip in PBS
mouse monoclonal antibodies and their antigen binding fragmentscontaining 20% FCS, 6 mM MgCl2, and 50 mg/ml DNase I (Sigma).
by fast protein liquid chromatography on a mono Q anion-exchangeThe cells were fixed for 30 min in 70% ethanol on ice and labeled
column. J. Chromatogr. 319, 67–77.with rabbit anti-GFAP and FITC-conjugated anti-rabbit antibodies
Coats, S.R., Love, H.D., and Pledger, W.J. (1994). Platelet-derivedin PBS containing 10% FCS. To analyze DNA content, 1 mg/ml
growth factor (PDGF)-AB-mediated phosphorylation of PDGF betaRNase A was present during the first antibody incubation (anti-
receptors. Biochem. J. 297, 379–384.GFAP) and 25 mg/ml propidium iodide (PI; Sigma) during the second
(anti-rabbit). Cells were analyzed by flow cytometry in a fluores- Connolly, D.T. (1991). Vascular permeability factor: a unique regula-
cence-activated cell scanner (FACS) (Becton-Dickinson) to quanti- tor of blood vessel function. J. Cell. Biochem. 47, 219–223.
tate GFAP-immunoreactivity and cellular DNA content. D’Amore, P.A. (1994). Mechanisms of retinal and choroidal neovas-
cularization. Invest. Ophthalmol. Vis. Sci. 35, 3974–3979.
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